Luca Porcu

A STUDY OF NIRAPARIB IN COMBINATION WITH ABEMACICLIB FOR LATE LINE TREATMENT OF OVARIAN CANCER: A SINGLE CENTER, OPEN LABEL, SINGLE ARM, PHASE IB/II TRIAL (NICHOL TRIAL NCT06594679)

CAPoxy: a feasibility study to investigate multispectral imaging in nailfold capillaroscopy

Unravelling the <i>in vivo</i> traits of vasculogenic mimicry

1739eTiP Chemio-immunotherapy in nai¨ve advanced Merkel cell carcinoma (MCC): The phase II PANDORA trial

IMMU-82. Neuronal modulation of immunity in glioblastoma

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC

Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatment

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry

Risk assessment of thromboembolic events in hospitalized cancer patients

The sacral chordoma margin

Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study

Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations

A broad Italian experience with eribulin mesylate in metastatic breast cancer patients: The ESEMPiO study.

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer